Esmolol for Treatment of Perioperative Tachycardia

NCT01208402 ↗

Phase 3 Terminated 76 enrolled Duke University Baxter Healthcare Corporation · collab

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to find out if Esmolol is a safe and effective alternative treatment compared to standard treatment using a long acting beta blocker drug, in controlling abnormal heart rate before, during and immediately after surgery.

Timeline

Start: 2010-09
Primary completion: 2013-07
Completion: 2013-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Esmolol	Other / unclassified	300 ug/kg	Other

Indications

No indication recorded.